UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Solitary fibrous tumors of the visceral pleura. 5 cases

La Presse médicale (1983), 1983-02, Vol.12 (9), p.561-564

1983

Volltextzugriff (PDF)

Multiple angioleiomyomas of both lungs. Probable hamartomatous tumors. Very late death due to respiratory insufficiency

Annales de médecine interne, 1976-02, Vol.127 (2), p.91

1976

Volltextzugriff (PDF)

5 new cases of solitary fibrous mesothelioma of the visceral pleura

Le Poumon et le coeur, 1983, Vol.39 (4), p.167

1983

Volltextzugriff (PDF)

The lung in monocional gammapatheis. Alternative hypotheses coming from a privileged observation (association of a diffuse interstitial fibrosis to a pulmonary tuberculosis then a disease of heavy gamma chains) (author's transl)

Le Poumon et le coeur, 1979, Vol.35 (3), p.167

1979

Volltextzugriff (PDF)

Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial

Annals of oncology, 2018-10, Vol.29, p.viii653-viii654

2018

Volltextzugriff (PDF)

Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Annals of oncology, 2019-10, Vol.30, p.v52

2019

Volltextzugriff (PDF)

165P - Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Annals of oncology, 2019-10, Vol.30, p.v52-v52

2019

Volltextzugriff (PDF)

1563P Early clinical trials in patients with pancreatic cancer: Assessment of factors limiting eligibility and effectiveness

Annals of oncology, 2020-09, Vol.31, p.S953-S953

2020

Volltextzugriff (PDF)

Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

Annals of oncology, 2018-10, Vol.29, p.viii378-viii379

2018

Volltextzugriff (PDF)

Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial

Annals of oncology, 2018-10, Vol.29, p.viii667-viii667

2018

Volltextzugriff (PDF)

34MO Outcomes according to FGFR alteration types in patients with a solid tumour treated by a pan-FGRF tyrosine kinase inhibitor in phase I/II trials

Annals of oncology, 2021-03, Vol.32, p.S14-S15

2021

Volltextzugriff (PDF)

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond

Journal of internal medicine, 2024-06, Vol.295 (6), p.785-803

2024

Volltextzugriff (PDF)

1452P Use of the Pallia 10 score in patients enrolled in phase I trials at Gustave Roussy Cancer Center

Annals of oncology, 2021-09, Vol.32, p.S1079-S1079

2021

Volltextzugriff (PDF)

LBA38 Bexmarilimab, a novel macrophage re-programmer shows promising anti-tumour activity in phase I/II trial in several last line solid tumour types

Annals of oncology, 2021-09, Vol.32, p.S1313-S1313

2021

Volltextzugriff (PDF)

1617P Sustained cancer clinical trial activity during the COVID-19 pandemic

Annals of oncology, 2021-09, Vol.32, p.S1151-S1151

2021

Volltextzugriff (PDF)

Clinical activity and safety of simlukafusp alfa, an engineered interleukin-2 variant targeted to fibroblast activation protein-α, combined with atezolizumab in patients with recurrent or metastatic cervical cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5510-5510

2021

Volltextzugriff (PDF)

47P Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs

Annals of oncology, 2020-12, Vol.31, p.S1435-S1435

2020

Volltextzugriff (PDF)

397PD - Precision medicine for patients with primary brain tumours: Molecular screening for cancer treatment optimization (MOSCATO) prospective trial

Annals of oncology, 2019-10, Vol.30, p.v146-v146

2019

Volltextzugriff (PDF)

Precision medicine for patients with primary brain tumours: Molecular screening for cancer treatment optimization (MOSCATO) prospective trial

Annals of oncology, 2019-10, Vol.30, p.v146

2019

Volltextzugriff (PDF)

Landscape of DNA damage response (DDR) genes alterations in the prospective MOSCATO and MATCH R trials

Annals of oncology, 2017-09, Vol.28, p.v596-v596

2017

Volltextzugriff (PDF)

A novel radiomic based imaging tool to monitor tumor lymphocyte infiltration and outcome of patients treated by anti-PD-1/PD-L1

Annals of oncology, 2017-09, Vol.28, p.v574-v574

2017

Volltextzugriff (PDF)

Long term survival in patients responding to an Anti-PD-1/PD-L1 therapy and disease outcome upon treatment discontinuation

Annals of oncology, 2017-09, Vol.28, p.v411-v411

2017

Volltextzugriff (PDF)

Precision medicine for patients with advanced biliary tract cancers: Updated results from the prospective MOSCATO trial

Annals of oncology, 2017-09, Vol.28, p.v247-v247

2017

Volltextzugriff (PDF)

Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene : a cystic fibrosis mutation of slavic origin common in Central and East Europe

Human genetics, 2000-03, Vol.106 (3), p.259-268

2000

Volltextzugriff (PDF)

165PEnhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(7)
Female
(5)
Life Sciences & Biomedicine
(3)
Science & Technology
(3)
Adult
(2)
Alleles
(2)
Cancer
(2)
Cystic Fibrosis - Genetics
(2)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(2)
Dna Mutational Analysis
(2)
Genetics
(2)
Genetics & Heredity
(2)
Immunotherapy
(2)
Male
(2)
Medical Sciences
(2)
Mesothelioma - Diagnostic Imaging
(2)
Mesothelioma - Pathology
(2)
Mesothelioma - Surgery
(2)
Oncology
(2)
Phenotype
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Solitary fibrous tumors of the visceral pleura. 5 cases

Multiple angioleiomyomas of both lungs. Probable hamartomatous tumors. Very late death due to respiratory insufficiency

5 new cases of solitary fibrous mesothelioma of the visceral pleura

The lung in monocional gammapatheis. Alternative hypotheses coming from a privileged observation (association of a diffuse interstitial fibrosis to a pulmonary tuberculosis then a disease of heavy gamma chains) (author's transl)

Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial

Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

165P - Enhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

1563P Early clinical trials in patients with pancreatic cancer: Assessment of factors limiting eligibility and effectiveness

Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial

Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial

34MO Outcomes according to FGFR alteration types in patients with a solid tumour treated by a pan-FGRF tyrosine kinase inhibitor in phase I/II trials

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond

1452P Use of the Pallia 10 score in patients enrolled in phase I trials at Gustave Roussy Cancer Center

LBA38 Bexmarilimab, a novel macrophage re-programmer shows promising anti-tumour activity in phase I/II trial in several last line solid tumour types

1617P Sustained cancer clinical trial activity during the COVID-19 pandemic

Clinical activity and safety of simlukafusp alfa, an engineered interleukin-2 variant targeted to fibroblast activation protein-α, combined with atezolizumab in patients with recurrent or metastatic cervical cancer

47P Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs

397PD - Precision medicine for patients with primary brain tumours: Molecular screening for cancer treatment optimization (MOSCATO) prospective trial

Precision medicine for patients with primary brain tumours: Molecular screening for cancer treatment optimization (MOSCATO) prospective trial

Landscape of DNA damage response (DDR) genes alterations in the prospective MOSCATO and MATCH R trials

A novel radiomic based imaging tool to monitor tumor lymphocyte infiltration and outcome of patients treated by anti-PD-1/PD-L1

Long term survival in patients responding to an Anti-PD-1/PD-L1 therapy and disease outcome upon treatment discontinuation

Precision medicine for patients with advanced biliary tract cancers: Updated results from the prospective MOSCATO trial

Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene : a cystic fibrosis mutation of slavic origin common in Central and East Europe

165PEnhanced performance of prognostic estimation from TCGA RNAseq data using transfer learning

Suchergebnisse filtern